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Background: Surgery is a cornerstone of treatment for malignancy. However, significant variation has been
reported in patterns and quality of cancer care for important health outcomes, including perioperative mortality.
Surgical process improvement tools (SPITs) have been developed that focus on enhancing the processes of care
at the point of care, as a means of quality improvement. This study describes SPITs and develops a conceptual
framework by synthesizing the available literature on these novel quality improvement tools.
Methods: A scoping review was conducted based on instruments developed for quality improvement in surgery.
The search was executed on electronically indexed sources (MEDLINE, EMBASE, and the Cochrane library) from
January 1990 to March 2011. Data were extracted, tabulated and reported thematically using a narrative synthesis
approach. These results were used to develop a conceptual framework that describes and classifies SPITs.
Results: 232 articles were reviewed for data extraction and analysis. SPITs identified were classified into 3 groups:
clinical mapping tools, structure communication tools and error reduction instruments. The dominant instrument
reported were clinical mapping tools, including: clinical pathways (113, 48%), fast track (46, 20%) and enhanced
recovery after surgery protocols (36, 15%). Outcomes reported included: length of stay (174, 75%), readmission
rates (116, 50%), morbidity (116, 50%), mortality (104, 45%), and economic (60, 26%). Many gaps in the literature
were recognized.
Conclusion: We have developed a conceptual framework of SPITs and identified gaps in current knowledge. These
results will guide the design and development of new quality instruments in surgery.
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Surgery is a central modality in the treatment of cancer.
The majority of patients with cancer will undergo a
surgical procedure during the course of their treatment,
for diagnostic, curative and/or palliative indications. For
solid tumors, surgery is the cornerstone of curative
treatment. As an example, for patients with colorectal
cancer, one of the most common causes of cancer in
high resource nations, resection is performed in 71-90%* Correspondence: Alice.Wei@uhn.ca
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reproduction in any medium, provided the orof patients. Surgery is the sole modality of treatment in
up to 53% of patients [1-6].
Despite the important role of surgery in the care of pa-
tients with cancer, the quality of surgical care is not uni-
form. Significant variation in the patterns of care delivery
and the quality of care has been reported, as reflected by
clinically important differences in quality outcomes such as
perioperative mortality and long-term survival [7-12]. For
many procedures, perioperative mortality has a strong in-
verse relationship with case volume. Better outcomes are
reported at high volume surgeons and/or institutions. The
strength of the relationship between volume and outcomes
is strongest for highly complex procedures such as cardiac
surgery, and/or pancreatectomy [8,9]. In Ontario Canada,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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rate in low volume hospitals compared to 3.4% in high vol-
ume hospitals [9] for pancreatectomy Similar trends have
been demonstrated, to a lower magnitude, in most other
cancer procedures including lung, breast and colorectal
procedures [8,12-21].
The means by which increased institutional volumes
affect outcome are complex and poorly understood.
Khuri et al. have argued that procedure volume does not
directly affect outcome and is likely a surrogate measure of
implicit quality of the systems of care [8,10,13,18,21-30]. As
a result, structural interventions are important but are in-
sufficient to realize optimal quality targets. We believe that
quality improvement interventions must move beyond
strategies that focus solely on structural changes in health
care delivery. We propose that gains in quality must include
direct interventions at the point of care –interventions that
improve the processes of care that are implemented at the
time of care delivery.
The goal of this study was to identify and characterize
the range of process improvement tools that have been
developed in cancer surgery. We used scoping review
methodology to synthesize and integrate the current lit-
erature. These data were used to develop a conceptual
framework of this family of instruments and identify po-
tential gaps in our knowledge about surgical process im-
provement instruments that warrant further evaluation
for primary research and development.Methods
Theoretical framework
There is currently no conceptual framework that inte-
grates process improvement instruments in surgery into
a single model. Within some individual areas (e.g. clin-
ical pathways), conceptual frameworks have been de-
scribed that model either the format and/or the intent of
each individual tool and/or related instruments.
This scoping review was designed to identify surgical
process improvement tools (SPITs) that shared the fol-
lowing properties:
1) Affect processes of care (i.e. practices involved in the
actual giving and receiving of care)
2) Involve interventions that are delivered at the point
of care (i.e. occur at the point in time when care is
delivered)
3) Aim to codify, make explicit, standardize and/or
operationalize processes of care
4) Incorporate current practices and/or introduce new
practices into the content of the instrument
We considered that these criteria would map out a
distinct group of quality improvement tools that shareda similar mechanism of action (process change) at a
similar point in the health care cycle (point of care).
Approach
We conducted a scoping review using various sources of
data, and by consulting with quality improvement ex-
perts. A scoping review is appropriate for a topic that
has not previously been thoroughly reviewed, or where
literature may be sparse [31]. Its purpose is to evaluate
the extent and nature of existing literature in areas
where either insufficient evidence exists in order to
conduct a systematic review or when synthesizing avail-
able evidence to begin describing a particular concept or
phenomenon, and generate research questions where
gaps in knowledge are revealed. This approach has been
selected for our research question, as this is the first
study (to our knowledge) that aims to integrate the dis-
parate literature on SPITs into a single family of related
quality improvement tools.
The methods are similar in rigor to a systematic re-
view, but selection criteria are developed post hoc based
on increasing familiarity with the literature, and detailed
information is extracted to help readers contextualize
the findings. The methods for extracting and describing
eligible literature, which is likely to be diverse and in-
clude both qualitative and quantitative studies, was
guided by Mays, who suggests that “narrative review” of
information from various types of studies is appropriate
for developing knowledge at an early stage in policy de-
velopment [31,32]. This involves thematic rather than
statistical analysis of information to explore concepts
and relationships, and consultation with experts to fur-




Several indexed, non-indexed and expert sources were
consulted. Search strategies were designed specific to the
sources, and combined concepts reflecting surgery and
tools or communication or quality or safety. Various stake-
holders representing physicians (Canadian Association of
General Surgeons), institutions (University Health Network
hospital administration) and policy level stakeholders
(Cancer Care Ontario) were engaged to review the ini-
tial selection criteria, in order to identify gaps in the
search strategy and to provide additional concepts that in-
formed the search strategy. Searches of indexed sources
were executed from January 1990 to March 2011, the
period during which concepts of quality improvement in
surgery gained traction. These databases included MED-
LINE (North American), the Cochrane Library (systematic
reviews, trials) and EMBASE (European). In addition, to
ensure that all relevant literature is captured, we hand
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that any seminal papers published prior to 1990 would be
retrieved from scanning the references of extracted studies.
Selection criteria
Preliminary selection criteria include quantitative (meta-
analyses, systemic reviews, surveys, observational stud-
ies, randomized trials) or qualitative (reviews/conceptual
analyses, interviews, focus groups) studies published in
English language peer-reviewed journals from January
1990 to March 2011 and limited to humans, provided
that they focused on developing or evaluating SPITs (as
defined above), and provided sufficient detail to extract
study design and findings. Studies were deemed ineligible
if they evaluated processes of care solely for the purposes of
performance management, such as studies that report re-
sults of quality indicators. Abstracts, addresses, autobiog-
raphies, bibliographies, biographies, comments, editorials,
letters and newspaper articles, were excluded
Selection methods
Titles and abstracts of the search results and select arti-
cles/tools were screened for inclusion based on eligibility
criteria. If more than one publication described a single
study, only most recent was included. Once the full text
articles and tools were retrieved, 2 abstractors independ-
ently extracted data. The initial selection criteria were
refined based on the information extracted during by
the initial scope of the literature. The updated selection
criteria were utilized to identify additional eligible items
for inclusion in the review.
Data analysis
Data extraction
A data extraction form was developed based on the
conceptual framework. Notable qualitative details were
identified on the data extraction form. Quality criteria
relevant to study design was developed using criterion
based approach [33-37] After meeting to compare the
data extracted from all selected studies, differences in
opinion between the abstractors were resolved through
consensus. Extracted data was tabulated and presented
thematically.
Data analysis and interpretation
The total number of eligible and included studies was
reported, along with reasons for exclusion. Contextual
information related to instrument design were examined
thematically according to May’s narrative synthesis ap-
proach [32]. Qualitative content that was highlighted
were reviewed in light of the proposed conceptual
framework. Revisions were made to the conceptual
framework, as guided by the nature and content of the
data extracted, in order to clarify emerging concepts.Tabulated findings were examined to discuss the instru-
ment type, quantity, design, study quality, clinical appli-
cations and relevant outcomes.
Results
The aim of this project was to examine the development
of SPITs in the area of cancer surgery. But, upon initial
scope, we found that studies that focused on SPITs for
cancer surgery was very limited. Thus, we modified our
search strategy to include all areas of surgery in order to
obtain a fuller view of the current literature.
The final search criteria extracted 7192 articles. 5480
remained after duplicates were removed, 4920 articles
were excluded based on criteria selected for the abstract
review (Figure 1). Abstracts were excluded if: they re-
ported clinical/medical effectiveness without description
of a process tool; concluded that a SPIT is needed with-
out description of development, implementation, or
evaluation; focused on teaching or training of health
professionals or trainees without tool development; fo-
cused on instruments to identify patient risk factors,
clinical conditions, quality of life, or with regard to pre-
operative anesthesia alone, dental procedures, or tech-
nology/computer tools; if the publication was a letter,
editorial, case study with less than 10 patients, or not
the most recent version of the research project. The
remaining 560 articles were fully reviewed for eligibility.
Of these, 212 articles were determined to meet all inclu-
sion criteria and none of the exclusion criteria. Twenty
additional articles were identified as relevant to this
research project after hand searching the references of
the eligible articles. Therefore, a total of 232 articles were
reviewed for data extraction and analysis (Additional
file 1: Table S1).
The quality of these studies was assessed using a cri-
terion approach for the presence of: detailed inclusion
and exclusion criteria, description of control group, tool
compliance, whether primary outcomes were explicitly
described and objective applied, and assessment or dis-
cussion of SPIT sustainability. Inclusion and exclusion
criteria were only reported in 120 out of 219 articles
(55%). When applicable, control groups were described
in 88 out of 136 of the articles (65%). Tool compliance
was reported in 59 out of 226 articles (26%). Primary
outcomes were explicitly described in 192 out of 228 ar-
ticles (84%) and the outcome criteria were considered
objectively applied in 138 out of 223 articles (62%). Sus-
tainability of the SPIT was only mentioned in 6 (3%) ar-
ticles (Table 1).
The majority of these studies were designed as either
an interventional (115, 49%) or observational (72, 31%)
assessment of the SPITs. Only 12 (5%) studies were
randomized controlled trials (Table 2). The majority of
articles study objectives were to: evaluate (120, 52%),
Figure 1 Scoping review search results.
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Only a few articles compared two or more SPITs (10,
4%) or discussed SPIT development (42, 18%) (Table 2).
The majority of these studies were completed at aca-
demic centers (158, 68%) and were located in the USA
(113, 48%) or Europe (55, 24%).
Only 67 (29%) of the studies evaluated SPITs in the
setting of cancer surgery. The majority of studies were
within the colorectal (53, 23%), abdominal- non-
colorectal (29, 12%), orthopedic (29, 12%), vascular (27,
12%), or cardiac surgical setting (27, 12%).
The most common SPITs were clinical pathways (113,
48%), fast-track protocols (46, 20%), and enhanced re-
covery after surgery (ERAS) protocols (36, 15%). Struc-
tured communication tools (17, 7%), checklists (16, 7%),
patient care planning/management (14, 6%), preparatory
pause (7, 3%) and patient safety (6, 3%) were less fre-
quently reported (Table 3). Outcomes evaluated in-
cluded: length of stay (174, 75%), readmission rates (116,
50%), morbidity (116, 50%), mortality (104, 44%) and








N % N % N %
Present 120 55 88 65 59 26
Absent 99 45 48 35 167 74
Unknown 0 0 0 0 0 0
Not applicable 13 6 96 41 6 3Data were extracted for statistically significant out-
comes. In articles that assessed these outcomes, length
of stay (146, 84%) and economic impacts (53, 88%) were
frequently reported as decreasing after implementation
of the SPIT. When reported, SPIT implementation ap-
peared to have no significant effect on morbidity (69,
59%), mortality (76, 73%) or readmission rates (86, 74%)
(Table 4).
Discussion
We report that the literature in the area of SPITs is pres-
ently under-investigated with only a handful of high
quality studies. Only 232 relevant studies were identified;
a mere 67 (29%) studies focused on cancer surgery. At
present the quality of literature in this area is low.
Nevertheless, this preliminary data suggests that these
instruments may be capable of effecting important qual-
ity improvements.
An important feature of the studies identified is that
patient-centered outcomes, such as mortality and mor-







N % N % N %
192 84 138 62 6 3
36 16 41 18 226 94
0 0 44 20 0 0
4 2 9 4 0 0
Table 2 Study design and objectives of SPITs articles
Study design N % Study objectives N %
Interventional 115 49 Tool evaluation 120 52
Observational 72 31 Tool implementation 105 45
Program evaluation 20 9 Tool description 91 39
Randomized controlled trial 12 5 Tool development 42 18
Systematic review 9 4 Tool comparison 10 4
Qualitative 3 1
Survey 1 0
Wei et al. BMC Surgery 2014, 14:45 Page 5 of 8
http://www.biomedcentral.com/1471-2482/14/45studies; they were reported as secondary outcomes. The
vast majority of studies focused on length of stay, cost
containment and improved efficiencies of care as pri-
mary study endpoints. These data indicate that SPITs
can reduce length of stay without negatively affecting
patient safety (i.e. morbidity, mortality or readmission
rates). Since patient-centered outcomes were only sec-
ondary endpoints, most studies were underpowered to
fully evaluate these outcomes. Thus future research will
be required to clarify whether SPITs has a positive im-
pact on the important patient-centered outcomes such
as morbidity, mortality and/or cancer survival.
Our study reveals important gaps in knowledge within
this area. Notably, few if any SPITs have been developed
for intraoperative processes of care. It is peculiar that
there were no SPITs that addressed any of the technical
components of a procedure. Another knowledge gap in-
cluded a paucity of SPITs that addressed the preopera-
tive evaluation or the postoperative surveillance of
cancer patients.
A conceptual framework of SPITs was developed based
on the results of this scoping review. We describe a
group of quality improvement tools that change the pro-
cesses of care, at the point of care. We grouped SPITs
into 3 categories of tools: structured communication
tools, clinical mapping tools and error reduction toolsTable 3 Type of SPITs reported in articles
Surgical process improvement tools (SPITs) N %
Clinical mapping instruments
Clinical pathway 113 48
Fast track protocol 46 20
Enhanced recovery after surgery protocols 36 15
Structured communication instruments
Structured communication tool 17 7
Checklist 16 7
Preparatory pause 7 3
Error reduction strategies
Patient care planning/management 14 6
Patient safety 6 3(Figure 2). These categories describe the major proper-
ties of the SPITs and reflect the main mechanism by
which they can improve quality of care. Since these tools
can have multiple mechanisms of action, they may have
properties that overlap into more than one category.
Gaps in current knowledge were also incorporated into
the framework to direct areas for future research.
Structured communication tools include instruments
such as: perioperative checklists, preparatory pauses, and
team briefings. These instruments focus on operational-
izing the steps of team communication and standardiz-
ing information exchange in specific settings [38-47].
The most common example in clinical use is the pre-
operative checklist - is primarily a structured communi-
cation tool, but elements of the checklist may involve
verification of essential safety steps. Thus through its de-
sign and content a checklist also has error checking
properties [39,40,48,49].
Clinical mapping tools are multi-disciplinary struc-
tured care plans that describe the timing and actions
required by providers in order for the patient to meet
target goals in a timely manner [50-53]. Clinical path-
ways are multi-disciplinary care maps that usually have a
time dependent inventory of action for a specific episode
of care. They have been widely implemented to improve
patient efficiencies, reduce length of stay and economic
costs through decreased variation in care delivery and
early identification of outliers [50-57]. Quality of care
has often been a secondary consideration for these in-
struments [55-60].
Some clinical mapping tools, such as enhanced recov-
ery strategies and fast track protocols, emphasize
pharmacologic changes or modification in current prac-
tices in order to facilitate early recovery (e.g. modifying
perioperative pain control to facilitate early mobilization,
early enteral feeding, etc.). Standardization of processes
is a by-product rather than a primary goal of enhanced
recovery strategies.
Error reduction instruments are developed to reduce the
incidence of preventable errors such as wrong site surgery
and/or errors in drug administration [44,46,47,61,62]. Often
these tools are targeted to eliminate ‘never’ events such as
wrong site/wrong patient surgery.
We postulate that SPITs can be described as a unique
family of quality improvement interventions. They can
be an important method of closing the knowledge-to-
action gap between evidence and practice. This family of
process improvement tools target process change as a
means to improve quality. To date, most have focused
on surrogate outcomes such as length of stay, cost, or
patient safety, rather than any direct measure of quality of
care such as perioperative morbidity, mortality and/or long
term survival or appropriateness of care. Thus, the end ef-
fect of these tools on quality is not well understood. Further
Table 4 Impact of SPIT for reported outcomes
Outcomes Increased Decreased No significant change Not reported
N % N % N % N %
Length of stay 0 0 146 84 17 10 11 6
Readmission rates 8 7 8 7 86 74 14 12
Morbidity 1 1 27 23 69 59 19 16
Mortality 0 0 14 13 76 73 14 13
Economic 0 0 53 88 3 5 3 5
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SPIT, and areas of mutual overlap are not known. Despite
the limited knowledge to date, we believe this family
of quality improvement tools is important because they
target processes of care and hold the potential to embed
evidence-based quality improvement at the point of care.
Further information is required about the relationship be-
tween this family of quality improvement instruments with
each other, and with important quality outcomes.
There are limitations in this scoping review. Our study
focused on SPITs instruments used in the immediate
perioperative period. This was emphasized in our search
strategy that required the term ‘surgery’ as a key elem-
ent. As a result, it is possible that SPITs used during the
early diagnostic and long-term surveillance period may
have been missed. For patients with cancer, surgery
usually makes up a small part of their cancer therapy.
Diagnosis and surveillance activities may not involve the
surgeon and therefore SPITs involving these activities
may be beyond the scope of this study. Nevertheless, we
would have expected that hand searching of articles refer-
ence would have at least key articles of note involving diag-
nosis and/or surveillance related SPITs. No substantialStructures Processe
Surgical Process Improveme
Structured Inter-professional Communication 
Instruments
Checklists
Team briefings/ debriefings/ preparatory pauses
Transfer of care instruments
Protocol driven communication (i.e. ‘sterile cockpit
Clinical Mapping Instruments
Clinical pathways/ care maps
Fast track/ enhanced recovery programs
Patient education/ preparation tools
Figure 2 SPITs conceptual framework.diagnostic or surveillance tools were identified in our scope.
As a result, we believe that this area remains an important
gap, requiring further research.
Conclusions
SPITs are innovative knowledge instruments that can
improve quality of health care by optimizing the pro-
cesses of care delivery. They can directly influence com-
ponents of care delivered, standardize and coordinate
elements of care, and enhance uptake of best evidence.
Importantly we sought to describe a group of tools that
work at the point-of-care. In this way, SPITs can change
the processes of care directly. This mechanism differs
from other knowledge translation strategies such as
continuing medical education strategies, which change
behavior in more indirect ways. We believe that the limi-
tations in the current knowledge provide opportunities
for new research.
At present these instruments are implemented in an
isolated fashion, without the benefit of a unified agenda
of quality improvement. We suggest that further devel-
opment and research into SPITs will demonstrate an im-





Crew resource management initiatives
Gaps in Current Knowledge
Tools addressing intra-operative SPITs
Tools for outpatient evaluation (pre-
operative and surveillance post-
operative)
Tools for diagnostic evaluation
’)
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of these types of knowledge products and unify them
into a family of related tools. We anticipate that the re-
sults of this study will guide the design and development
of new SPIT instruments for use with patients undergo-
ing cancer surgery.
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of SPITs.
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